Most Recent
US drug maker Cosette wants to strike out Mayne Pharma's causation pleading in its suit seeking damages after Cosette allegedly inducing the treasurer to reject their $672 million tie-up.
A class action against Johnson & Johnson over alleged ineffective cold medicine has attacked the pharmaceutical company’s application for soft class closure, telling a court the process would produce useless data and only need to be repeated.
Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark.
Construction PRO
Real estate fund manager Charter Hall Group has added to its social infrastructure portfolio with the $445 million acquisition of Sonic Healthcare's major pathology facility in the Brisbane CBD.
Oral care company Hismile has paid $138,600 in penalties after the consumer watchdog issued it with seven infringement notices over alleged false and misleading social media advertisements.
Construction PRO
A new $16 million day hospital built below a Fitness Cartel in Perth's Osborne Park has succeeded in maintaining an injunction against the gym, granted after the hospital reported that constant noise and vibrations were disrupting medical procedures.
Noting the aging group members, a judge has pushed the parties in two class actions against aged care facilities over COVID-19 outbreaks to shoot for a 2027 or early-2028 trial date.
Kicking off its appeal of a finding that it couldn't walk away from a $672 million merger agreement with Mayne Pharma, US drug company Cosette has told a court that Mayne was not upfront about its financial position prior to the deal.
US drug maker Cosette is appealing a judge’s decision not to disqualify himself from Mayne Pharma's lawsuit seeking damages over the termination of their $672 million if he is appointed to case manage the dispute.
A union representing medical officers has lost its appeal of a ruling which found that junior doctors at state-run hospitals in NSW are not temporary employees who are entitled to a 10 per cent allowance.